Skip to main content

Day: August 14, 2020

Knight Therapeutics Completes the Tender Offer for Grupo Biotoscana And Achieves Over 95% Ownership

MONTREAL, Aug. 14, 2020 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight“), a leading pan-American (ex-US) specialty pharmaceutical company, today announced the results of the tender offer process (“Tender Offer”) for the acquisition of all outstanding Brazilian Depositary Receipts (“BDRs”) of Biotoscana Investments S.A. (“GBT”). A total of 49,778,512 of BDRs were tendered by BDR holders thereby resulting in Knight owning 98% of all outstanding GBT shares and BDRs. The settlement of the Tender Offer shall occur on August 18, 2020 (“Settlement Date”). On the Settlement Date, Knight will payout a total of R$517,837,423.Based on the results provided by B3 S.A. – Brasil, Bolsa, Balcão on the date hereof: (a) 169,757 BDRs were tendered at the Offer Price. Accordingly, Knight shall pay R$11.23 per BDR to the...

Continue reading

Parachèvement par Thérapeutique Knight de l’offre publique d’achat de Grupo Biotoscana et obtention de plus de 95 % de propriété

MONTRÉAL, 14 août 2020 (GLOBE NEWSWIRE) — Thérapeutique Knight inc. (TSX : GUD), société pharmaceutique spécialisée et chef de file panaméricaine (ex. EU) (« Knight »), a annoncé aujourd’hui les résultats de la vente aux enchères suivant le processus d’offre publique d’achat (l’« offre publique d’achat ») pour l’acquisition de tous les certificats de dépôts brésiliens (« BDR ») de Biotoscana Investments S.A. (« GBT »). Lors de la vente aux enchères, 49,778,512 BDR au total ont été soumis, permettant à Knight de détenir 98% de toutes les actions et BDR de GBT en circulation. Le règlement de l’offre publique d’achat aura lieu le 18 août 2020 (« date de règlement »). À la date de règlement, Knight paiera un total de 517,837,423 BRL.Selon les résultats transmis par B3 S.A. – Brasil, Bolsa, Balcão à la date des présentes : a) 169,757...

Continue reading

EnviroLeach Announces Resignation of Director

VANCOUVER, British Columbia, Aug. 14, 2020 (GLOBE NEWSWIRE) — EnviroLeach Technologies Inc. (the “Company “or “EnviroLeach”), (CSE: ETI) (OTCQB: EVLLF) (7N2: FSE) announces Jack Kiland has resigned as a director of the Company due to health reasons, effective immediately.The Board of Directors and management of Enviroleach would like to thank Jack for his significant contributions to to the Company since its inception and wish him well as he focusses on his health.About EnviroLeach Technologies Inc.EnviroLeach Technologies is engaged in the development and commercialization of environmentally-friendly formulas and technologies for the treatment of materials in the mining and recycling sectors. Using its proprietary non-cyanide, water-based, neutral pH treatment process EnviroLeach extracts precious metals from ores, concentrates,...

Continue reading

Skyline Announces Operational Results for the Three and Six Months Ended June 30, 2020 and Provides COVID-19 Operational Update

Cash and cash equivalents increased by $3.2 million during Q2 2020 despite the worst economic quarter the world has ever experienced;Q2 2020 revenue from Skyline’s hotels and resorts was $7.0 million compared to $45.8 million in Q2 2019, an unprecedented decline of 85% due to the impact of COVID-19;Skyline’s operating expenses from hotels and resorts also declined by 68% including the effect of subsidies received in response to the crisis;EBITDA for the first six months of 2020 remained positive at $2.3 million versus $23.7 million in the first half of 2019;Unrestricted cash and available lines of credit as at June 30, 2020 totalled approximately $44 million;Occupancy of all of the Company’s US hotels and Canadian resorts show a steady improvement from their lows in April;The Company received independent, third-party appraisals for 73%...

Continue reading

Resverlogix Announces Private Placement

CALGARY, Alberta, Aug. 14, 2020 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) announced today it has closed a private placement of 3,573,333 equity units at a price of $0.75 per unit for gross proceeds of approximately $2.7 million (US$2.0 million). Each unit was comprised of one common share and one-half (1/2) of a common share purchase warrant. Each full warrant is exercisable at a price of $1.00 per share for a period of one year from the closing of the private placement. The units are subject to a four-month hold period.After giving effect to the private placement, the Company has a total of 216,663,554 common shares issued and outstanding. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (“Hepalink”) subscribed for all 3,573,333 units; it holds 85,286,524 common shares...

Continue reading

Dealnet Reports Second Consecutive Quarterly Profit

Second quarter net income of $165 thousand increased by 45% over Q1 profit of $114 thousandCall centre maintains high service levels through COVID-19Delinquent accounts declined by 8% from March 31Further reduction in corporate overheads to less than $1 million per monthCash balance of $8.8 million as of June 30 (March 31, 2020 – $4.7 million)Originations rebounding stronglyTORONTO, Aug. 14, 2020 (GLOBE NEWSWIRE) — Dealnet Capital Corp. (“Dealnet” or the “Company”) (TSX VENTURE: DLS), reported today its financial results for the quarter ended June 30, 2020. All results are reported under International Financial Reporting Standards (“IFRS”) and in Canadian dollars, unless otherwise specified.Net income of $279 thousand in the first half of 2020, an increase of $1.5 million over the results from...

Continue reading

Cequence Energy Provides Update on Continuous Disclosure Filings

CALGARY, Alberta, Aug. 14, 2020 (GLOBE NEWSWIRE) — Cequence is relying on exemptive relief granted by Canadian securities regulatory authorities in light of the COVID-19 pandemic (the “Exemptive Relief”) that allows it to delay the filing of its interim financial report for the interim period ended June 30, 2020 as required by section 4.4 of National Instrument 51-102 and related management’s discussion & analysis as required by subsection 5.1(2) of National Instrument 51-102 (collectively, the “Q2 Filings”). Until such time as these filings are made, Cequence’s management and other insiders are subject to a trading blackout that reflects the principles contained in section 9 of National Policy 11-207 – Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions. Except as previously announced by Cequence...

Continue reading

Nxt-ID, Inc. Announces Investor Webcast to Discuss the Financial Results for the Six and Three Months Ended June 30, 2020 and to Provide a General Corporate Update

Oxford, Connecticut, Aug. 14, 2020 (GLOBE NEWSWIRE) — Nxt-ID, Inc. (NASDAQ: NXTD) (the “Company”), a provider of healthcare devices and services, announces results for the six and three months ended June 30, 2020.Financial Highlights and results from the second quarter included:Revenue for the six and three months ended June 30, 2020 was approximately $6.2 million and $2.5 million, respectively, down significantly in both periods as compared to the same 2019 periods.Gross profit for the six and three months ended June 30, 2020 was approximately $4.6 million and $1.8 million, respectively compared to approximately $6.6 million and $3.4 million for the same 2019 periods.Operating expenses for the six and three months ended June 30, 2020 were approximately $3.7 million and $1.9 million, respectively compared to $5.5 million and $2.8...

Continue reading

Eve & Co Announces Financial Results for the Three and Six Months Ended June 30, 2020

STRATHROY, Ontario, Aug. 14, 2020 (GLOBE NEWSWIRE) — Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSX-V: EVE; OTCQX: EEVVF) is pleased to announce its financial results for the three and six months ended June 30, 2020. The financial statements and management’s discussion and analysis for such period are available on the System for Electronic Document Analysis and Retrieval (“SEDAR”) at www.sedar.com and on Eve & Co’s website at www.evecannabis.ca.ABOUT EVE & COEve & Co, through its wholly-owned subsidiary Natural MedCo Ltd. (“NMC”), holds cultivation and processing licences under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and extraction of cannabis oil and has received EU GMP certification. NMC was...

Continue reading

Genius Brands International Issues Statement in Connection With Second Quarter 10-Q Filing

BEVERLY HILLS, Calif., Aug. 14, 2020 (GLOBE NEWSWIRE) — Genius Brands International, Inc. (“Genius Brands” or the “Company”) (NASDAQ:GNUS), the global brand management company that creates and licenses multimedia entertainment content for children, today filed its 10-Q for the quarterly period ended June 30, 2020. The filing is available at: https://ir.gnusbrands.com/all-sec-filings.Genius Brands Chairman & CEO Andy Heyward said:“The Second Quarter of 2020 brought with it many exciting and pivotal developments at Genius Brands.We launched Kartoon Channel! and announced with it the appointment of two of Hollywood’s most accomplished and proven executives, Margaret Loesch as Executive Chairman and David Neuman as Chief Content Officer. The channel launched June 15th with notable shows like Angry Birds, Baby Einstein, Minecraft...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.